Suzhou Highfine Biotech (301393.SZ) traded flat 0 % during a 24 hours period ending at 10:39 PM Central Europe on Monday 26th. One Suzhou Highfine Biotech stock can currently be bought for about CNY 56.68 on popular exchanges. Current supply of Suzhou Highfine Biotech stocks is 107.2 mn. Suzhou Highfine Biotech has a current market capitalization of CNY 6.3 bn and approximately CNY 199 mn worth of Suzhou Highfine Biotech was traded on exchanges in the last 24 hours. Since last month end, Suzhou Highfine Biotech has traded -12.53 % down. Simple moving average of last 200 days is at CNY 59.79. The highest price of past 52 weeks was recorded at CNY 74.68 on 07/15/2026. 52 weeks low was at CNY 46.69 on 03/04/2026.
Here is how related stocks have performed in the past 24 hours:
Beijing Wandong Medical Te (600055.SS) traded flat 0 % and now trades at CNY 11.11. Current market capitalisation for Beijing Wandong Medical Te is CNY 7.5 bn.
Zhejiang Guyuelongshan Sha (600059.SS) traded flat 0 % and now trades at CNY 8.35. Current market capitalisation for Zhejiang Guyuelongshan Sha is CNY 7.5 bn. Current price/earnings ratio for Zhejiang Guyuelongshan Sha is 33.28. ZHEJIANG GUYUELONGSHAN SHA reported its third‑quarter results on October 22. Revenue for the period declined slightly compared with the prior year, while net profit rose, reflecting a modest improvement in earnings. The company highlighted continued progress in its strategic partnership with Beijing Sugar and Alcohol Group, which is accelerating the launch of a joint flagship yellow‑wine product aimed at capturing the upcoming festival market. In addition, the firm received recognition for its environmental initiatives, being named a provincial green factory in Zhejiang. Market activity for the sector remains uneven, with a mix of gains and declines among peers, but Guyuelongshan’s performance suggests a gradual return to growth ahead of the forthcoming earnings season.
Shenzhen Best Of Best Hold (001298.SZ) traded flat 0 % and now trades at CNY 16.8. Current market capitalisation for Shenzhen Best Of Best Hold is CNY 7.5 bn. Shenzhen Best of Best Holdings experienced a modest rise in its trading session, reflecting broader market recovery after a late‑afternoon rebound. The company’s share price benefited from a sector‑wide lift driven by positive sentiment surrounding physical artificial‑intelligence developments and renewed investor interest in technology and consumer‑goods stocks. While the firm’s movement mirrored the upward trend of its peers, it remained within the broader rally that saw several leading names in the semiconductor and retail sectors enjoy notable gains. Overall, the day’s performance underscored a continued resilience in the technology and consumer sectors amid a supportive macro‑economic backdrop.
Jihua (601718.SS) traded flat 0 % and now trades at CNY 1.73. Current market capitalisation for Jihua is CNY 7.5 bn.
Bio-thera (688177.SS) traded flat 0 % and now trades at CNY 18.01. Bio-thera has a market capitalisation of CNY 7.5 bn.
About Suzhou Highfine Biotech
Suzhou Highfine Biotech Co Ltd. is a Chinese biotechnology company based in Shenzhen, listed on the Shenzhen Stock Exchange.